NO992005D0 - New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes - Google Patents

New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes

Info

Publication number: NO992005D0
Authority: NO; Norway
Prior art keywords: syndromes; estrogen; prevention; treatment; related diseases
Prior art date: 1996-10-28

Application number

NO992005A

Other languages

Norwegian (no)

Other versions

NO992005L (en

Inventor

Poul Jacobsen

Svend Treppendahl

Paul Stanley Bury

Anders Kanstrup

Lise Brown Christiansen

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-28

Filing date

1999-04-27

Publication date

1999-04-27

1999-04-27 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1999-04-27 Publication of NO992005D0 publication Critical patent/NO992005D0/en

1999-06-25 Publication of NO992005L publication Critical patent/NO992005L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Physical Education & Sports Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrane Compounds (AREA)

NO992005A 1996-10-28 1999-04-27 New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes NO992005L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK119996		1996-10-28
PCT/DK1997/000485 WO1998018778A1 (en)	1996-10-28	1997-10-28	Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

Publications (2)

Publication Number	Publication Date
NO992005D0 true NO992005D0 (en)	1999-04-27
NO992005L NO992005L (en)	1999-06-25

Family

ID=8102089

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO992005A NO992005L (en)	1996-10-28	1999-04-27	New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes

Country Status (8)

Country	Link
EP (1)	EP0934299A1 (en)
JP (1)	JP2001502710A (en)
AU (1)	AU4772297A (en)
CA (1)	CA2270056A1 (en)
IL (1)	IL129618A0 (en)
NO (1)	NO992005L (en)
WO (1)	WO1998018778A1 (en)
ZA (1)	ZA979649B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0944613B1 (en) *	1996-12-13	2002-10-09	Chugai Seiyaku Kabushiki Kaisha	Benzopyran derivatives
JP2000119187A (en) *	1998-10-15	2000-04-25	Taisho Pharmaceut Co Ltd	Composition for preventing or improving depressed mood
US8080675B2 (en)	2004-09-21	2011-12-20	Marshall Edwards, Inc.	Chroman derivatives, medicaments and use in therapy
WO2006032085A1 (en)	2004-09-21	2006-03-30	Novogen Research Pty Ltd	Substituted chroman derivatives, medicaments and use in therapy
EP2635273B1 (en)	2010-11-01	2020-01-08	MEI Pharma, Inc.	Isoflavonoid compositions and methods for the treatment of cancer
AU2016215515B2 (en)	2015-02-02	2020-04-30	Mei Pharma, Inc.	Combination therapies
CN120665056A (en) *	2019-12-12	2025-09-19	冰洲石生物科技公司	Novel chroman derivatives having estrogen receptor degrading activity and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3340276A (en) *	1964-04-01	1967-09-05	Ciba Geigy Corp	3, 4-diphenyl-chromans
DE1543749A1 (en) *	1966-02-16	1969-12-11	Merck Ag E	Process for the preparation of 3,4-cis-4-aryl-isoflavans
US5280040A (en) *	1993-03-11	1994-01-18	Zymogenetics, Inc.	Methods for reducing bone loss using centchroman derivatives
HUP9702244A3 (en) *	1995-01-13	1999-12-28	Novo Nordisk As	Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders

1997
- 1997-10-28 JP JP10519944A patent/JP2001502710A/en active Pending
- 1997-10-28 WO PCT/DK1997/000485 patent/WO1998018778A1/en not_active Ceased
- 1997-10-28 EP EP97910266A patent/EP0934299A1/en not_active Withdrawn
- 1997-10-28 IL IL12961897A patent/IL129618A0/en unknown
- 1997-10-28 CA CA002270056A patent/CA2270056A1/en not_active Abandoned
- 1997-10-28 ZA ZA9709649A patent/ZA979649B/en unknown
- 1997-10-28 AU AU47722/97A patent/AU4772297A/en not_active Abandoned
1999
- 1999-04-27 NO NO992005A patent/NO992005L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP0934299A1 (en)	1999-08-11
ZA979649B (en)	1998-04-28
NO992005L (en)	1999-06-25
AU4772297A (en)	1998-05-22
IL129618A0 (en)	2000-02-29
JP2001502710A (en)	2001-02-27
WO1998018778A1 (en)	1998-05-07
CA2270056A1 (en)	1998-05-07

Similar Documents

Publication	Publication Date	Title
ID18925A (en)	1998-05-20	THE USE OF SUBSTITUTED BENZAZOLS AS UV ABSORBENS, NEW BENZAZOLS AND PROCESSES FOR THE PRODUCTION
NO944857D0 (en)	1994-12-14	Fluorenyl-containing metallocenes, process for their preparation and process for polymerization of olefins using the metallocenes
NO954942L (en)	1996-02-07	New erythromycin derivatives, processes for their preparation and use of the derivatives as drugs
ATE350364T1 (en)	2007-01-15	ADAMANTAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND CARDIOVASCULAR DISEASES
NL1001338C2 (en)	1996-04-12	2-Hydroxyphenyltriazines, process for their preparation and use of UV absorbers.
NO900613D0 (en)	1990-02-08	PROCEDURE FOR THE PREPARATION OF ACTIVATED CHITOSANES AND USE IN THE PREPARATION OF CHITOSANDER DERIVATIVES.
FI921260A0 (en)	1992-03-24	PROCEDURE FOR THE PROCESSING OF PROFILES.
TR199500952A2 (en)	1996-07-21	New n-benzylindole and benzopyrazole derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effect.
NO864241L (en)	1988-04-25	PROCEDURE FOR BLACKING CELLULOSMASS OR FRAGMENT THEREOF, PLANT FOR USE BY IMPLEMENTATION OF THE PROCEDURE AND SCREW PRESSURE, SPECIFICALLY FOR USE BY THE PROCEDURE UNDER THE APPLICATION.
NO911956L (en)	1991-11-25	PROCEDURE FOR THE PREPARATION OF OXYDANT SENSITIVE AND INSENSITIVE, AROMATIC ESTERS AS HUMAN NEUTROPHIL ELASTASE INHIBITORS
NO992010D0 (en)	1999-04-27	New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO983261L (en)	1998-07-15	New Benzoylguanidine Derivatives, Methods of Preparing Them and Using Them in the Preparation of Medicines
NO995723L (en)	2000-01-21	New triptolide derivatives useful in the treatment of autoimmune diseases
NO992009D0 (en)	1999-04-27	New trans-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO992005D0 (en)	1999-04-27	New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO171484C (en)	1993-03-24	APPLICATION OF SUGARCARCOOL, POLYOXYLYCYLENETS OR ETHMONOSACCHARIDE OR MIXTURES THEREOF BASED FOR SOMATOSTATINES AND CALCITONINES FOR AA INCREASED BIOTAILABILITY OF THE PEPTIDES ORAL OR RECTAL.
NO992008D0 (en)	1999-04-27	New (+) enantiomers of cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO995722L (en)	2000-01-21	New triptolide derivatives useful in the treatment of autoimmune diseases
MX22991A (en)	1994-02-28	SWEETENING AGENT DERIVED FROM L-ASPARTIC OR L-GLUTAMIC ACID AND THE PROCEDURE FOR ITS PREPARATION.
NO953989D0 (en)	1995-10-06	New polycyclic systems and derivatives thereof, such as neurotransmitter release-seeking agents useful in the treatment of cognitive disorders
NO992002D0 (en)	1999-04-27	New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO992004D0 (en)	1999-04-27	New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO992006L (en)	1999-06-25	New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
FI971245L (en)	1997-05-28	Anti-inflammatory factor, method for isolating it and its use
NO992007D0 (en)	1999-04-27	Novel (-) Enantiomers of cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes

Legal Events

Date	Code	Title	Description
2002-06-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application